Cargando…
Limitations of Specific Coagulation Tests for Direct Oral Anticoagulants: A Critical Analysis
BACKGROUND: During treatment with direct oral anticoagulants (DOAC), coagulation assessment is required before thrombolysis, surgery, and if anticoagulation reversal is evaluated. Limited data support the accuracy of DOAC‐specific coagulation assays around the current safe‐for‐treatment threshold of...
Autores principales: | Ebner, Matthias, Birschmann, Ingvild, Peter, Andreas, Härtig, Florian, Spencer, Charlotte, Kuhn, Joachim, Rupp, André, Blumenstock, Gunnar, Zuern, Christine S., Ziemann, Ulf, Poli, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404908/ https://www.ncbi.nlm.nih.gov/pubmed/30371316 http://dx.doi.org/10.1161/JAHA.118.009807 |
Ejemplares similares
-
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants
por: Ebner, Matthias, et al.
Publicado: (2017) -
Specific Point-of-Care Testing of Coagulation in Patients Treated with Dabigatran
por: Härtig, Florian, et al.
Publicado: (2021) -
Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants including edoxaban
por: Härtig, Florian, et al.
Publicado: (2021) -
Point-of-care testing of coagulation in patients treated with edoxaban
por: Härtig, Florian, et al.
Publicado: (2020) -
UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and Its Comparison with Functional Assays
por: Kuhn, Joachim, et al.
Publicado: (2015)